Zolmax logo

The Latest Headlines at Zolmax

Image about Ericsson (NASDAQ:ERIC) Receives $11.00 Average Target Price from Brokerages

Ericsson (NASDAQ:ERIC) Receives $11.00 Average Target Price from Brokerages

Ericsson (NASDAQ:ERIC – Get Free Report) has been given an average recommendation of “Hold” by the nine analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock... More of this article »
Image about Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Average Rating of “Moderate Buy” by Analysts

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Average Rating of “Moderate Buy” by Analysts

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat Ratings reports. Two research... More of this article »
Image about Viasat Inc. (NASDAQ:VSAT) Receives $90.67 Consensus Price Target from Brokerages

Viasat Inc. (NASDAQ:VSAT) Receives $90.67 Consensus Price Target from Brokerages

Shares of Viasat Inc. (NASDAQ:VSAT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven research firms that are presently covering the stock, MarketBeat.com reports. One research... More of this article »
Image about Genelux (NASDAQ:GNLX) Downgraded by Wall Street Zen to “Strong Sell”

Genelux (NASDAQ:GNLX) Downgraded by Wall Street Zen to “Strong Sell”

Wall Street Zen cut shares of Genelux (NASDAQ:GNLX – Free Report) from a sell rating to a strong sell rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings reissued a “sell (e+)”... More of this article »
Image about Cognition Therapeutics (NASDAQ:CGTX) Downgraded to “Sell” Rating by Wall Street Zen

Cognition Therapeutics (NASDAQ:CGTX) Downgraded to “Sell” Rating by Wall Street Zen

Wall Street Zen cut shares of Cognition Therapeutics (NASDAQ:CGTX – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning. Other equities analysts have also issued reports... More of this article »
Image about MindWalk (NASDAQ:HYFT) Upgraded by Wall Street Zen to Hold Rating

MindWalk (NASDAQ:HYFT) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of MindWalk (NASDAQ:HYFT – Free Report) from a sell rating to a hold rating in a report issued on Saturday. Other equities research analysts also recently issued reports about the company. Weiss... More of this article »
Image about Seabridge Gold (NYSE:SA) Upgraded by Wall Street Zen to Hold Rating

Seabridge Gold (NYSE:SA) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of Seabridge Gold (NYSE:SA – Free Report) (TSE:SEA) from a sell rating to a hold rating in a report published on Saturday. A number of other research firms also recently commented on SA. B. Riley... More of this article »
Image about FB Bancorp (NASDAQ:FBLA) Upgraded by Wall Street Zen to “Hold” Rating

FB Bancorp (NASDAQ:FBLA) Upgraded by Wall Street Zen to “Hold” Rating

Wall Street Zen upgraded shares of FB Bancorp (NASDAQ:FBLA – Free Report) from a sell rating to a hold rating in a research report released on Saturday. Separately, Weiss Ratings raised FB Bancorp from a “sell (d+)”... More of this article »
Image about JAKKS Pacific (NASDAQ:JAKK) Downgraded to Buy Rating by Wall Street Zen

JAKKS Pacific (NASDAQ:JAKK) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen lowered shares of JAKKS Pacific (NASDAQ:JAKK – Free Report) from a strong-buy rating to a buy rating in a research note released on Saturday morning. A number of other analysts also recently commented on JAKK.... More of this article »
Image about Mako Mining (NASDAQ:MAKO) Downgraded to “Hold” Rating by Wall Street Zen

Mako Mining (NASDAQ:MAKO) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen cut shares of Mako Mining (NASDAQ:MAKO – Free Report) from a strong-buy rating to a hold rating in a report published on Saturday morning. MAKO has been the subject of a number of other reports. Weiss Ratings... More of this article »
Image about MakeMyTrip (NASDAQ:MMYT) Upgraded to Hold at Wall Street Zen

MakeMyTrip (NASDAQ:MMYT) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of MakeMyTrip (NASDAQ:MMYT – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Several other equities research analysts also recently weighed in... More of this article »
Image about Karat Packaging (NASDAQ:KRT) Upgraded by Wall Street Zen to “Buy” Rating

Karat Packaging (NASDAQ:KRT) Upgraded by Wall Street Zen to “Buy” Rating

Wall Street Zen upgraded shares of Karat Packaging (NASDAQ:KRT – Free Report) from a hold rating to a buy rating in a research report report published on Saturday. Other equities research analysts have also issued research reports... More of this article »
Image about Niu Technologies (NASDAQ:NIU) Lowered to “Strong Sell” Rating by Wall Street Zen

Niu Technologies (NASDAQ:NIU) Lowered to “Strong Sell” Rating by Wall Street Zen

Wall Street Zen cut shares of Niu Technologies (NASDAQ:NIU – Free Report) from a hold rating to a strong sell rating in a research note issued to investors on Saturday. Separately, Weiss Ratings restated a “sell (d-)”... More of this article »
Image about Organigram Global (NASDAQ:OGI) Upgraded to Hold at Wall Street Zen

Organigram Global (NASDAQ:OGI) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Organigram Global (NASDAQ:OGI – Free Report) from a sell rating to a hold rating in a report issued on Saturday morning. Separately, Weiss Ratings reissued a “sell (d)” rating on... More of this article »
Image about Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded to Buy at Wall Street Zen

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Free Report) from a hold rating to a buy rating in a research note released on Saturday. Separately, Weiss Ratings upgraded Oramed Pharmaceuticals from... More of this article »